; (2) panels should be updated monthly or quarterly; and (3) PCPs should have a mechanism and incentives to enroll patients so they can influence who is attributed to their panel. 3. Improving coverage for Medicare home infusion (a) In general The HHS Secretary shall establish reimbursement for home infusion services and associated equipment and items under part B. (b) Covered services and supplies Home Infusion Therapy (HIT) and associated equipment are defined to include— (1) equipment (e.g., mechanical pumps) for drug administration of Eligible Infusion Drugs; (2) items (other than drugs and equipment) used in connection with the delivery of Eligible Infusion Drugs such as disposable supplies for the drug administration (e.g., tubing, elastomeric pumps) and for the routine maintenance of the infusion access device; (3) 24/7 availability of pharmacist professional services such as assessments, drug preparation and compounding, dispensing, clinical monitoring, administrative, and education; and (4) 24/7 availability of nursing services (when not provided as part of a home health episode). (c) Qualified providers Provided by a qualified home infusion therapy services supplier as defined in section 1861(iii)(3)(C) of this Act. (d) Eligible infusion drugs Eligible part B and part D Infusion Drugs are defined as parenteral drugs or biologics administered through intravenous, intrathecal, intra-arterial, or subcutaneous access device, except— (1) drugs and biologics on the self-administered drug list